bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.21.758783

AgamOBP4-targeted drug repurposing identifies novel mosquito repellent scaffolds

Abstract

Odorant-binding proteins (OBPs) play central roles in insect chemoreception and represent attractive molecular targets for the discovery of novel behavior-modifying compounds. We report two crystal structures of Anopheles gambiae OBP4: one complexed with the fluorescent probe N-phenyl-1-naphthylamine and a second containing two indole molecules simultaneously bound within the ligand-binding cavity. Structural comparison revealed two binding subsites accommodating the aromatic moieties of 1-NPN or two indole molecules, while identifying Thr58 and Thr70 as key residues in ligand recognition. A structure-based virtual screening campaign was performed against a volatility-filtered library from DrugBank, FooDB, BioNet, and natural-volatiles datasets. Twenty-three ligands were selected for fluorescence competitive binding assays, identifying four AgamOBP4 binders with micromolar affinities (Ki = 2.4-21.8 M). Among them were benzoyl peroxide, an active anti-acne ingredient, Avex-73 (blarcamesine), a clinical-stage drug candidate, and 2-phenylethyl benzoate, a food- and fragrance-associated ester. Additional candidates include O,p'-DDE, a metabolite of the insecticide DDT, and fluorene, a polycyclic aromatic hydrocarbon detected in foods as environmental or processing-derived contaminants. Seven selected compounds were subsequently evaluated against Aedes albopictus in in-vivo behavioral assays, with benzoyl peroxide displaying the highest repellency (RI = 81.8% at 0.2 mg cm-2). AI-based protein-ligand modeling provided insights into ligand recognition and suggested relationships among binding mode, binding affinity, and bioactivity. Collectively, these findings establish the structural basis of ligand recognition by AgamOBP4, highlight the potential of drug-repurposing and food-derived chemical space as sources of next-generation mosquito repellents, and open new opportunities for the development of OBP4-based biosensors for food-quality and environmental monitoring applications.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Alonso-Fernandez, J.-R., Stamati, E. C. V., Drakou, C. E., Mazavli, M., Karras, V., Papachristos, D. P., Michaelakis, A., Zographos, S. E., Perez-Sanchez, H., Tsitsanou, K. E.. 2026-10-22. AgamOBP4-targeted drug repurposing identifies novel mosquito repellent scaffolds. https://doi.org/10.64898/2026.10.21.758783

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The structures of two intermediates en route to DNA repair within a (6-4) photolyase

Pyrimidine (6-4) pyrimidone photoproducts (6-4PPs) are mutagenic DNA lesions produced when UV light crosslinks two adjacent pyrimidine bases. These lesions must be repaired to maintain genome integrity, a function executed by the (6-4) photolyase enzymes. This repair chemistry is complex, involving the transfer of a hydroxyl group from one base to another, accompanied or followed by cleavage of an interbase bond. It remains unclear how the enzyme orchestrates this reaction. Typically, models invoke a stepwise process in which an oxetane intermediate is transiently populated, but despite over thirty years of investigation, such an intermediate has never been definitively observed. Conducting dose-controlled X-ray crystallography on the (6-4) photolyase from Vibrio cholerae, we observed the transformation of 6-4PP into an oxetane species. Furthermore, we identified a previously unanticipated hemi-cleaved intermediate. The progressive transformation of 6-4PP into oxetane, hemi-cleaved, and fully repaired species requires a reexamination of the existing models of DNA repair by (6-4) photolyases.

biochemistry↗

Endothelial protein C receptor is an entry receptor for Langya virus

Langya virus (LayV) was recently discovered in infected individuals with febrile illness and classified as a Parahenipavirus, a group of poorly understood pathogens. LayV is distantly related to Nipah henipavirus which causes recurring outbreaks with case fatality rates reaching up to 90%. No vaccines or therapeutics are approved for use in humans for any parahenipavirus or henipavirus despite their broad geographic distribution and pandemic potential. Here, we discovered that human endothelial protein C receptor (EPCR) is an entry receptor for LayV and that the tetrameric LayV attachment glycoprotein (G) binds EPCR avidly. We reveal the molecular basis of LayV G recognition of the EPCR receptor and provide a blueprint of the determinants of receptor ortholog usage. We found that human and shrew EPCR orthologs promote cell entry of LayV and of the closely related Mojiang pseudoviruses. These results along with the detection of several Parahenipaviruses in shrews set these pathogens apart from Henipaviruses, which use Pteropid fruit bats as reservoir hosts. Our data support future surveillance efforts, by enabling prediction of EPCR utilization among newly discovered Parahenipaviruses, and the development and evaluation of countermeasures targeting this emerging group of human pathogens.

biochemistry↗

RNA-targeted aminopyridine compounds provide a new antifungal strategy

While RNA is an emerging therapeutic target class, progress is limited by a shortage of well-defined targets in which ligand binding is coupled to measurable function. The group I intron, a self-splicing ribozyme essential in fungal mitochondria but absent from humans, offers both a tractable platform for exploring first principles of small molecule-RNA targeting and a selective antifungal target. We recalibrated an intron-splicing assay to approximate cellular conditions and performed an extensive, cryo-EM-guided structure-activity relationship campaign against the Candida albicans mtLSU intron. Ligands containing a flexible diamine outperformed conformationally constrained analogues, suggesting a general principle for engaging dynamic RNA surfaces and yielding lead aminopyridine 56 (IC 21.6 nM). Compound 56 synergizes with amphotericin B against C. albicans, suggesting a path for combination therapies. RT-qPCR confirmed direct target engagement in cells. This work establishes the fungal group I intron as a viable, mechanistically distinct antifungal target and a model platform for RNA-targeted discovery.

biochemistry↗